Neisseria Meningitidis Group A Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, Neisseria Meningitidis Group C Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, Neisseria Meningitidis Group Y Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen, And Neisseria Meningitidis Group W-135 Capsular Polysaccharide Tetanus Toxoid Conjugate Antigen
Generic Name: neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide tetanus toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide tetanus toxoid conjugate antigen
Brand Names:
Menquadfi
Dosage form: INJECTION, SOLUTION. Route: INTRAMUSCULAR. Active ingredients: NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN (10 ug/.5mL); NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN (10 ug/.5mL); NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN (10 ug/.5mL); NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN (10 ug/.5mL). Category: BLA.
Overview
Dosage form: INJECTION, SOLUTION. Route: INTRAMUSCULAR. Active ingredients: NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN (10 ug/.5mL); NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN (10 ug/.5mL); NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN (10 ug/.5mL); NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN (10 ug/.5mL). Category: BLA.
Dosage
Available as injection, solution for intramuscular use.
Related Medications
Insulin Aspart Recombinant
insulin aspart recombinant
Manufactured by NOVO NORDISK INC. Dosage form: INJECTABLE. Route: SUBCUTANEOUS. Active ingredients: INSULIN ASPART PROTAMINE RECOMBINANT (50 UNITS/ML); INSULIN ASPART RECOMBINANT (50 UNITS/ML). Application: BLA021810.
Mirdametinib
mirdametinib
Kinase Inhibitor [EPC]
11 DESCRIPTION GOMEKLI capsules and tablets for oral suspension contain mirdametinib, a kinase inhibitor. Mirdametinib is chemically known as (R)-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2- fluoro-4-iodophenyl)amino) benzamide. The molecular formula is C 16 H 14 F 3 IN 2 O 4 and the molecular weight is 482.20 g/mol. The structural formula for mirdametinib is: Mirdametinib is a white to tan or pink solid with an aqueous solubility of 0.25 mg/mL and a pH of 7.2 in water at 25°C.
Viscum Alb, Crataegus Oxy, Baryta Carb, Aurum Mur, Ars Alb, Arum Lod, Baryta Lodata
viscum alb, crataegus oxy, baryta carb, aurum mur, ars alb, arum lod, baryta lodata
Uses Temporarily supports blood flow. Temporarily relieves discomfort due to circulatory concerns, including occasional leg cramps when walking, skin temperature fluctuations, racing pulse, headaches, dizziness, memory problems, and mood changes.* *CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE, NOT ACCEPTED MEDICAL EVIDENCE, NOT FDA EVALUATED. This product is not intended to diagnose, treat, cure, or prevent any disease.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.